JP2024542610A5 - - Google Patents
Info
- Publication number
- JP2024542610A5 JP2024542610A5 JP2024531580A JP2024531580A JP2024542610A5 JP 2024542610 A5 JP2024542610 A5 JP 2024542610A5 JP 2024531580 A JP2024531580 A JP 2024531580A JP 2024531580 A JP2024531580 A JP 2024531580A JP 2024542610 A5 JP2024542610 A5 JP 2024542610A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- ring
- compound
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2117127.7A GB202117127D0 (en) | 2021-11-26 | 2021-11-26 | Compounds |
| GB2117127.7 | 2021-11-26 | ||
| PCT/GB2022/053000 WO2023094830A1 (en) | 2021-11-26 | 2022-11-25 | Sulfonamide compounds for the treatment of neurological conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542610A JP2024542610A (ja) | 2024-11-15 |
| JP2024542610A5 true JP2024542610A5 (enExample) | 2025-11-19 |
Family
ID=80038556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531580A Pending JP2024542610A (ja) | 2021-11-26 | 2022-11-25 | 神経学的状態の治療のためのスルホンアミド化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250115569A1 (enExample) |
| EP (1) | EP4436955A1 (enExample) |
| JP (1) | JP2024542610A (enExample) |
| KR (1) | KR20240111787A (enExample) |
| CN (1) | CN118317950A (enExample) |
| AU (1) | AU2022396783A1 (enExample) |
| CA (1) | CA3237721A1 (enExample) |
| GB (1) | GB202117127D0 (enExample) |
| IL (1) | IL312851A (enExample) |
| MX (1) | MX2024006436A (enExample) |
| WO (1) | WO2023094830A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202308160D0 (en) * | 2023-05-31 | 2023-07-12 | Lario Therapeutics Ltd | Compounds |
| GB202308164D0 (en) * | 2023-05-31 | 2023-07-12 | Lario Therapeutics Ltd | Compounds |
| GB202308165D0 (en) * | 2023-05-31 | 2023-07-12 | Lario Therapeutics Ltd | Compounds |
| IT202400001329A1 (it) * | 2024-01-24 | 2025-07-24 | Lario Therapeutics Ltd | Composti. |
| WO2025158150A1 (en) * | 2024-01-24 | 2025-07-31 | Lario Therapeutics Limited | Heterocyclic compounds as modulators of cav2.3 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8623859B2 (en) * | 2008-08-22 | 2014-01-07 | Evotec Ag | Bradykinin B1 antagonists |
| US20130190356A1 (en) * | 2011-12-22 | 2013-07-25 | Genentech, Inc. | Benzyl sulfonamide derivatives as rorc modulators |
| EP2994463B1 (en) * | 2013-05-07 | 2017-10-25 | Galapagos NV | Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis |
| EP2998294A1 (en) * | 2014-09-16 | 2016-03-23 | Sanofi | Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders |
| ES2992748T3 (en) | 2017-06-14 | 2024-12-17 | Lario Therapeutics Ltd | Antagonists of cav2.3 r-type calcium channels for the treatment of neurodegenerative diseases |
-
2021
- 2021-11-26 GB GBGB2117127.7A patent/GB202117127D0/en not_active Ceased
-
2022
- 2022-11-25 JP JP2024531580A patent/JP2024542610A/ja active Pending
- 2022-11-25 WO PCT/GB2022/053000 patent/WO2023094830A1/en not_active Ceased
- 2022-11-25 IL IL312851A patent/IL312851A/en unknown
- 2022-11-25 EP EP22817332.4A patent/EP4436955A1/en active Pending
- 2022-11-25 US US18/713,009 patent/US20250115569A1/en active Pending
- 2022-11-25 CN CN202280078485.9A patent/CN118317950A/zh active Pending
- 2022-11-25 KR KR1020247020803A patent/KR20240111787A/ko active Pending
- 2022-11-25 CA CA3237721A patent/CA3237721A1/en active Pending
- 2022-11-25 AU AU2022396783A patent/AU2022396783A1/en active Pending
- 2022-11-25 MX MX2024006436A patent/MX2024006436A/es unknown